Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susanne Kloss"'
Autor:
Peter Hammerer, Christine Windemuth-Kieselbach, Salah-Eddin Al-Batran, Carsten Lange, Thorsten H. Ecke, Ralf-Dieter Hofheinz, Burkhard Linsse, Susanne Kloss
Publikováno v:
BJU international. 119(5)
Objective To examine health-related quality of life (QoL) in men with metastatic castration-resistant prostate cancer (mCRPC) on cabazitaxel. Patients and Methods Men with mCRPC receiving cabazitaxel (25 mg/m², every 3 weeks) and 10 mg/day oral pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07be30ea30112388ce72ec831135a03c
https://pubmed.ncbi.nlm.nih.gov/27618249
https://pubmed.ncbi.nlm.nih.gov/27618249
Publikováno v:
Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere. 32:88-91
Zusammenfassung: Gegenstand und Ziel: Im Gegensatz zur Hündin liegen bei der Katze bisher wenige Studien über die genitale Keimflora geschlechtsgesunder Tiere vor. Ziel der Untersuchung war daher, physiologische Daten über die aerobe Vaginalflora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0152e4772024c4dc67ebe3e90243449
https://doi.org/10.1055/s-0037-1622406
https://doi.org/10.1055/s-0037-1622406
Publikováno v:
Berliner und Munchener tierarztliche Wochenschrift. 115(7-8)
The incidence of dystocia from ewes in nine lambing periods (1992-2000) was recorded at an obstetrical clinic. First we analysed parturition difficulties in normal pregnant sheep (group 1, n = 229). In the second group parturitions of ewes with vagin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::213d807db074863ccff33b31819a965c
https://pubmed.ncbi.nlm.nih.gov/12174720
https://pubmed.ncbi.nlm.nih.gov/12174720
Autor:
Michael Staehler, Joerg Schmitz, Friedrich Overkamp, Manfred Kindler, Christian Doehn, Edwin Herrmann, Gernot Guderian, Gabriel Steiner, Susanne Kloss, Peter J. Goebell, Thomas Steiner, Ulrich Kube, Steffen Weikert, Lothar Bergmann, Andreas Jakob, Jan Janssen
Publikováno v:
Journal of Clinical Oncology. 30:e15044-e15044
e15044 Background: Everolimus (EVE, Afinitor) is approved for the treatment of metastatic renal cell cancer (mRCC) after failure of VEGF-targeted therapy. The option to treat mRCC with six approved targeted agents has sparked debate on proper sequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::031265267b7bb2eb13fa3fdc5b04fb56
https://doi.org/10.1200/jco.2012.30.15_suppl.e15044
https://doi.org/10.1200/jco.2012.30.15_suppl.e15044
Autor:
Christian Doehn, Ulrich Kube, Michael Staehler, Thomas Steiner, Susanne Kloss, Peter J. Goebell, Gabriel Steiner, Gernot Guderian, Friedrich Overkamp, Joerg Schmitz, Andreas Jakob, Jan Janssen, Manfred Kindler, Thomas Koepke, Steffen Weikert, Lothar Bergmann
Publikováno v:
Journal of Clinical Oncology. 30:361-361
361 Background: Everolimus (EVE, Afinitor) is approved for the treatment of metastatic renal cell cancer (mRCC) after failure of VEGF-targeted therapy. The option to treat mRCC with six approved targeted agents has sparked debate on proper sequencing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c94ccd882d46536def4b239a79aba838
https://doi.org/10.1200/jco.2012.30.5_suppl.361
https://doi.org/10.1200/jco.2012.30.5_suppl.361